Apotex launches nilotinib capsules, the first generic version of Tasigna®(1) in the United States, with 180 days of exclusivity
Apotex Corp.today announced the launch of nilotinib capsules, a generic version of Tasigna®, in the United States, with 180 days of exclusivity. https://mma.prnewswire.com/media/2696669/Apotex_Inc__Apotex_launches_nilotinib_capsules__the_first_generi.jpg Nilotinib is a kinase inhibitor indicated to treat certain types of leukemia, including newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (“Ph+ CML”) in chronic phase in adults and children aged 1 […]